SARA KAROWADIA: Open Payments
NPI 1861123770 · MISSOURI CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,129 in 104 payments from 20 companies in 2025. Trend: 2023 $333 · 2024 $106 · 2025 $2,129
Food & beverage: $2,129
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 10 | $316 |
| ABBVIE INC. | 25 | $287 |
| Regeneron Healthcare Solutions, Inc. | 12 | $265 |
| GENZYME CORPORATION | 6 | $234 |
| Janssen Biotech, Inc. | 15 | $213 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $157 |
| Journey Medical Corporation | 1 | $124 |
| Galderma Laboratories, L.P. | 6 | $106 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $100 |
| UCB, Inc. | 3 | $76 |
Products named: DUPIXENT, OPZELURA, TREMFYA, SKYRIZI, RINVOQ, ILUMYA, Bimzelx, Winlevi.
Industry payments across TX — which companies pay providers there.
